NCT06015685

Brief Summary

The purpose of this study is to improve diabetes management for patients at Midtown General Internal Medicine Clinic (Aim 1). The clinic offers dedicated diabetes care on certain days with trained providers able to offer dedicated diabetes care. The clinic will also make sure to address other aspects of life and health that may impact an individual's ability to manage their diabetes - food insecurity, housing insecurity, knowing about healthy food, finding ways to exercise, and mental health. The study will also train the medical residents to be able to participate in this dedicated diabetes care (Aim 2).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 29, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

October 20, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 24, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 24, 2025

Completed
Last Updated

February 13, 2026

Status Verified

February 1, 2026

Enrollment Period

1.3 years

First QC Date

August 22, 2023

Last Update Submit

February 10, 2026

Conditions

Keywords

Primary CareContinuous Glucose Monitoring (CGM)Diabetes ManagementMultidisciplinary care

Outcome Measures

Primary Outcomes (3)

  • Change in the proportion of embedded clinic patients with an HbA1c >9%

    Percentage of participants with HbA1c \>9% since the embedded clinic implementation. Data will be assessed from electronic medical records (EMR)

    Baseline and 6 months

  • Change in acceptability of intervention measure (AIM)

    AIM score is a four-item measures of implementation outcomes that are often considered "leading indicators" of implementation success (likert scale 1-5 with 5 being best outcome) at the baseline and 6-month follow-up visits will be used by the team members to assess the acceptability of model implementation.

    Baseline and 6 months

  • Change in feasibility of intervention measure (FIM) scores

    FIM score is a four-item measures of implementation outcomes that are often considered "leading indicators" of implementation success likert scale 1-5 with 5 being best outcome) at the baseline and 6-month follow-up visits will be used by the team members to assess the feasibility of model implementation.

    Baseline and 6 months

Secondary Outcomes (9)

  • Change in weight

    Baseline, 3 months, and 6 months

  • Change in body mass index (BMI)

    Baseline, 3 months, and 6 months

  • Change in diabetes self-efficacy score

    Baseline, 3 months, and 6 months

  • Change in depression status

    Baseline, 3 months, and 6 months

  • Change in the patient-reported quality of life score

    Baseline, 3 months, and 6 months

  • +4 more secondary outcomes

Study Arms (2)

Embedded clinic at Midtown

EXPERIMENTAL

Using the Emory Clinical Data Warehouse (CDW), all patients of Emory Primary Care Midtown with HbA1c \>9% who are not currently under the care of an endocrinologist or the diabetes management program at Emory will be invited to participate in this embedded DM management clinic.

Other: Embedded Clinic

Routine Care- Dunwoody Family Medicine Clinic

OTHER

The control population will be drawn using electronic health record data of diabetes patients at Dunwoody Family Medicine Clinic. Information from the Electronic Health Record will be de-identified after extraction. Control participants will be frequency matched.

Other: Routine Care

Interventions

Once a week, a Primary Care clinic half-day will be dedicated to multi-disciplinary, team-based DM care. The inter-professional team will include an Internal Medicine attending physician, an Internal Medicine resident, a DM educator, a nurse trained in professional CGM, a behavioral health provider, and a social worker to assist in finding resources for housing, food, and patient assistance programs.

Also known as: multi-disciplinary, team-based DM care
Embedded clinic at Midtown

Researchers will use a 2:1 ratio of control to intervention patients. Using the CDW, researchers will identify a control population \[patients who receive routine care (i.e., referral to subspecialty care)\], who will be a propensity-matched cohort of individuals with similar age, gender, race/ethnicity, zip codes, insurance type, visit dates, and co-morbidities (Charlson Comorbidity Index) as the intervention group.

Also known as: Control Group
Routine Care- Dunwoody Family Medicine Clinic

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18+
  • Patient at Midtown Diabetes Clinic
  • Able to consent
  • HbA1c \>=9%

You may not qualify if:

  • Not planning to follow up at Midtown
  • Pregnancy
  • Followed by Endocrinology as a specialist
  • Aim 2 (Embedded diabetes clinic and curriculum):
  • \- All residents in Midtown Primary Care are eligible

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emory Primary Clinic Care at Midtown

Atlanta, Georgia, 30308, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Britt A Marshall, MD

    Emory University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 22, 2023

First Posted

August 29, 2023

Study Start

October 20, 2023

Primary Completion

January 24, 2025

Study Completion

January 24, 2025

Last Updated

February 13, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

The research team will share deidentified individual participant's data that underlie the results reported in the article after deidentification (text, tables, figures, and appendices)

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
The research team will share the deidentified data immediately following publication, with no known end date.
Access Criteria
Data will be shared with researchers who provide a methodologically sound proposal to achieve the aims specified in their proposal All proposals should be sent to britt.marshall@emory.edu.

Locations